• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC Pipelines in Oncology: Genentech

On September 7, 2012 The Dana-Farber/Harvard Cancer Center Pipelines in Oncology program will host Genentech. They will hold a 12:30 p.m. - 2:00 p.m. seminar in Smith 308/309 to provide an overview of their pipeline. They will present on:

 

Immunotherapy, PI3K, Armed Abs (ADCs), MetMab, Hedgehog

 

They will also hold Roundtable discussions at MGH in the morning and at DFCI in the afternoon. Please indicate if you are interested in the roundtable discussions in your reply.

 

2:00 - 4:00 p.m. in Smith 308/309 Discussion/Roundtable with DFCI Investigators

MetMab, Hedgehog, BRAFi, MEKi

 

2:00 - 4:00 p.m. in Smith 304: Discussion/Roundtable with DFCI Investigators

PI3K, Armed Abs (ADCs), and Immunotherapy

 

Here is the team that will present:

Stuart Lutzker, MD, PhD Vice-President Exploratory Clinical Development

Chris Bowden MD, Vice President BioOncology, Clinical Development

Terry Rugg, MD, Vice-President, US Medical Affairs

Mika Derynck, MD, Senior Group Medical Director

Jennifer Low, MD, Group Medical Director, BioOncology

Bernard Fine, MD, Associate Group Medical Director

Dan Chen MD, PhD, Associate Group Medical Director

Gilbert Jirau-Lucca, MS, Principal Medical Science Director, Scientific Collaborations